• Lifestance Health Group Inc LFST.OQ reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of six analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -5 cents to -2 cents per share.

• Revenue rose 16% to $325.48 million from a year ago; analysts expected $313.72 million.

• Lifestance Health Group Inc's reported EPS for the quarter was a loss of 2 cents​.

• The company reported a quarterly loss of $7.11 million.

• Lifestance Health Group Inc shares had risen by 1.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 36.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Lifestance Health Group Inc is $9.50

This summary was machine generated from LSEG data February 27 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)